Fibroblast Growth Factor 2 and Its Receptors in Bone Biology and Disease
Open Access
- 28 May 2018
- journal article
- review article
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 2 (7) , 657-671
Abstract
The Fibroblast Growth Factor (FGF) regulatory axis is phylogenically ancient, evolving into a large mammalian/human gene family of 22 ligands that bind to four receptor tyrosine kinases for a complex physiological system controlling cell growth, differentiation and metabolism. The tissue targets for the primary FGF function are mainly cartilage and in bone for morphogenesis, mineralization and metabolism. A multitude of complexities in the FGF ligand-receptor-signaling pathways have made translation into therapies for FGF related bone disorders such as osteomalacia, osteoarthritis and osteoporosis difficult, but not prohibitive.Keywords
This publication has 148 references indexed in Scilit:
- Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating AchondroplasiaThe American Journal of Human Genetics, 2012
- Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney diseaseExperimental Cell Research, 2012
- The impaired bone anabolic effect of PTH in the absence of endogenous FGF2 is partially due to reduced ATF4 expressionBiochemical and Biophysical Research Communications, 2011
- FGF23 in Skeletal Modeling and RemodelingCurrent Osteoporosis Reports, 2011
- Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanismJournal of Bone and Mineral Research, 2011
- Polymorphisms in predicted miRNA binding sites and osteoporosisJournal of Bone and Mineral Research, 2010
- Neogenin Regulation of BMP-Induced Canonical Smad Signaling and Endochondral Bone FormationDevelopmental Cell, 2010
- Regulation of gene expression in osteoblastsBioFactors, 2010
- Adverse Effects of Bisphosphonates: Implications for Osteoporosis ManagementMayo Clinic Proceedings, 2009
- Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor‐2 in cardiovascular development and diseaseDevelopmental Dynamics, 2009